持股变动声明
CervoMed(CRVO)06-15 06:25
$CervoMed(CRVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-020411 Size: 5 KB 网页链接
简介:CervoMed Inc.于2015年6月18日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,致力于通过提高目前标准治疗(包括放射治疗和化疗)的有效性延长癌症患者的预期寿命。
今开:14.33 | 昨收:14.41 |
最高:14.88 | 最低:13.89 |
涨停价: | 跌停价: |
总市值:114644462 |
CervoMed(CRVO)06-15 06:25
$CervoMed(CRVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-020411 Size: 5 KB 网页链接
CervoMed(CRVO)06-15 06:35
$CervoMed(CRVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-020413 Size: 5 KB 网页链接
CervoMed(CRVO)07-23 19:35
$CervoMed(CRVO)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-24-023240 Act: 34 Size: 165 KB 网页链接
CervoMed(CRVO)05-11 05:15
$CervoMed(CRVO)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001437749-24-016060 Act: 33 Size: 7 MB 网页链接
CervoMed(CRVO)06-06 18:05
$CervoMed(CRVO)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001437749-24-019384 Act: 33 Size: 2 MB 网页链接
CervoMed(CRVO)06-06 18:05
$CervoMed(CRVO)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001754 Act: 33 Size: 2 KB 网页链接
CervoMed(CRVO)06-15 06:25
$CervoMed(CRVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-020408 Size: 5 KB 网页链接
CervoMed(CRVO)05-16 05:15
$CervoMed(CRVO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-24-017132 Act: 34 Size: 193 KB 网页链接
CervoMed(CRVO)05-15 04:15
$CervoMed(CRVO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-24-016615 Act: 34 Size: 4 MB 网页链接
CervoMed(CRVO)06-15 06:25
$CervoMed(CRVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-020410 Size: 5 KB 网页链接
美股滚雪球2023-08-18 10:19
$Diffusion制药(DFFN)$ 和EIP制药(EIP Pharma)合并以及反向股票分割之后,新设立的$CervoMed(CRVO)$ 股票在交易的第一天飙升。
周二晚些时候,Diffusion宣布股东批准了合并。该公司还计划在上市前进行1比1.5的反向拆股,以符合纳斯达克的上市要求。合并后公司的股票原定于8月17日开始交易。
$CervoMed(CRVO)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-24-023240 Act: 34 Size: 165 KB 网页链接
$CervoMed(CRVO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-24-022658 Act: 34 Size: 187 KB 网页链接
$CervoMed(CRVO)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001437749-24-022659 Act: 33 Size: 63 KB 网页链接
$CervoMed(CRVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-020414 Size: 6 KB 网页链接
$CervoMed(CRVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-020413 Size: 5 KB 网页链接
$CervoMed(CRVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-020410 Size: 5 KB 网页链接
$CervoMed(CRVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-020408 Size: 5 KB 网页链接
$CervoMed(CRVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-020409 Size: 5 KB 网页链接
$CervoMed(CRVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-020411 Size: 5 KB 网页链接
$CervoMed(CRVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-020412 Size: 5 KB 网页链接